Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

Share Price is delayed by 15 minutes
Get Live Data
4.85    -0.10 (-2.02%)
Bid:
4.86
Ask:
5.12
Spread: 0.26 (5.35%)
Market Cap: £42.18m
REVB Live PriceLast checked at - London Stock Exchange

Intraday Revolution Beauty Share Chart

Trading Update & response to boohoo Group REPLACE

23 Jun 2023 08:02

RNS Number : 7283D
Revolution Beauty Group PLC
23 June 2023
 

The following replaces the 'Update on current trading and response to recent announcement from boohoo Group plc' announcement released on 23 June 2023 at 7am BST under RNS No 6638D.

The previously released announcement included the incorrect comparator period for EBITDA and cash on hand. The correct comparator is Q1 FY23, rather than Q1 FY24. All other aspects of the announcement are unchanged.

The full amended text is shown below.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

For immediate release

23 June 2023

 

 

REVOLUTION BEAUTY GROUP PLC

("Revolution Beauty", the "Group" or the "Company")

 

Update on current trading and response to recent announcement from boohoo Group plc

Current trading performance

Revolution Beauty Group plc (AIM: REVB), the multi-channel mass beauty innovator, is today providing an update on trading for the first three months of the financial year ending 28 February 2024. The Board believes that it is appropriate to update all shareholders on the Group's most recent trading performance in light of the hostile requisition notice (the "Requisition") received by boohoo Group plc ("boohoo").

Trading has been excellent during this period, with sales up 60% year on year. Gross margins were 48.2%, which compares with 41.7% in the corresponding period last year. EBITDA at constant currency was £3.5m (Q1 FY23: £7.4m loss) and cash on hand was £15.4m (Q1 FY23: £10.1m). This performance demonstrates the quality of Revolution Beauty's products and consumer offer, and its ability to deliver growing sales into an expanding global retailer base.

boohoo's stated rationale for the proposed changes to the Revolution Beauty board is that the focus of the Group must switch to growth. The Company hopes that shareholders are reassured that the current board is similarly minded and that growth is being delivered without one shareholder taking control of the board at the expense of the interests of other shareholders. It is also noteworthy that the Group's trading performance has been delivered at the same time as rectifying the significant historical issues that occurred under previous management.

Response to recent announcement from boohoo

As previously stated, the board of Revolution Beauty is focussed on ensuring value creation at this critical time for the Company, which is on the cusp of having trading in its shares on AIM restored. The board believes that boohoo's hostile Requisition is value-destructive, opportunistic and self-serving, as well as not being in the interests of the Company's shareholders as a whole.

The Group notes the announcement released on 22 June 2023 by boohoo, stating boohoo's intention to include Rachel Horsefield (the former CEO of Beauty at THG plc ("THG"), a business with which Revolution Beauty has recently undertaken to cease commercial relationships) in the future independent board appointment process of Revolution Beauty. According to boohoo's announcement, Ms Horsefield "brings with her a wealth of direct relevant experience and expertise in the beauty sector".

The board of Revolution Beauty believes that boohoo's announcement yesterday vindicates its view, as stated in the Company's announcement of 21 June 2023, that Alistair McGeorge and Neil Catto (boohoo's two current board candidates for Revolution Beauty) do not have the relevant experience in running a business in the beauty sector, nor in supplying a store estate and beauty product range which is focussed on the high street.

The board of Revolution Beauty continues to be of the view that it is much better placed than the proposed boohoo candidates to deliver shareholder value. Together with a broad executive leadership team with significant beauty and e-commerce expertise, the Company reminds shareholders that, in Jeremy Schwartz, they already have a director with a wealth of experience in the beauty sector. Jeremy spent 12 years at L'Oréal, including as managing director in the UK responsible for all consumer, luxury, salon and active cosmetics divisions, and five years as chairman and CEO of The Body Shop, which has some 3,000 stores in 70 countries. Therefore, Ms Horsefield's proposed addition to the board is not required.

As previously announced, the Company also intends to appoint Rachel Maguire and Matthew Eatough as non-executive directors, who will bring robust challenge, fresh ideas and support as the business continues to grow.

Bob Holt, Chief Executive Officer, said:

"The excellent trading performance in the first quarter of the year is testament to the quality of our offer and the strength of our leadership team, and shows that we are delivering on our global retailer strategy. This has been achieved at the same time as fixing the historical issues overseen by previous management and putting in place improved cost controls and processes across the business.

Revolution Beauty has clear positive momentum and we remain focused on restoring trading in the Company's shares. We have a strong platform in place to deliver continued profitable growth".

For further information please contact:

Revolution Beauty Investor Relations

Bob Holt / Elizabeth Lake

Investor.Relations@revolutionbeautyplc.com

 

Joint Corporate Brokers

Zeus (NOMAD): Nick Cowles / Jamie Peel / Jordan Warburton

Liberum: Clayton Bush / Edward Thomas / Miquela Bezuidenhoudt

 

Tel: +44 (0) 161 831 1512

Tel: +44 (0) 203 100 2222

Media enquiries:

Headland Consultancy

Matt Denham / Will Smith / Antonia Pollock

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

 

The person responsible for arranging the release of this announcement on behalf of the Company is Bob Holt, the Chief Executive Officer of the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAKKDASXDEEA
Date   Source Headline
30th Mar 20237:00 amRNSUpdate on timing of FY22 Results and Financing
7th Mar 20232:00 pmRNSRevised deferred consideration for Medichem
21st Feb 20237:00 amRNSUpdate on FY22 Audit
13th Jan 20237:00 amRNSOutcome of Independent Investigation
16th Dec 20222:35 pmRNSDirectorate Change
28th Nov 20222:24 pmRNSHolding(s) in Company
28th Nov 20227:00 amRNSAppointment of CEO
25th Nov 20224:27 pmRNSTR-1: Standard notification of major holdings
9th Nov 20229:05 amRNSDirectorate Change
27th Oct 20225:30 pmRNSSuspended Companies Notice – Deletions
14th Oct 20227:00 amRNSUpdate on Independent Investigation
23rd Sep 20227:00 amRNSFurther update on the Group’s audit
23rd Sep 20227:00 amRNSFurther update on the Group’s audit
7th Sep 20227:00 amRNSTR-1: Standard notification of major holdings
1st Sep 20227:30 amRNSSuspension - Revolution Beauty Group plc
30th Aug 20227:00 amRNSUpdate on Publication of Final Results
19th Aug 20222:30 pmRNSFurther update on the Group’s audit
17th Aug 20226:20 pmRNSTR-1: Standard notification of major holdings
17th Aug 20226:15 pmRNSTR-1: Standard notification of major holdings
17th Aug 20226:00 pmRNSTR-1: Standard notification of major holdings
17th Aug 20227:05 amRNSStrategic Investment in Revolution Beauty Group
17th Aug 20227:00 amRNSTR-1: Standard notification of major holdings
17th Aug 20227:00 amRNSTR-1: Standard notification of major holdings
12th Aug 20221:55 pmRNSTR-1: Standard notification of major holdings
11th Aug 20224:41 pmRNSSecond Price Monitoring Extn
11th Aug 20224:35 pmRNSPrice Monitoring Extension
11th Aug 202211:05 amRNSUpdate on the Group’s audit
11th Aug 202210:10 amRNSTR-1: Standard notification of major holdings
5th Aug 20221:20 pmRNSTR-1: Standard notification of major holdings
3rd Aug 20223:45 pmRNSTR-1 Standard notification of major holdings
2nd Aug 20227:00 amRNSTrading update and change to results date
30th Jun 20227:00 amRNSCorporate Broker Appointment and Notice of Results
17th Jun 20227:00 amRNSNOTIFICATION OF MAJOR HOLDINGS
12th May 20227:00 amRNSAppointment of Chief Financial Officer
11th May 202211:40 amRNSHolding(s) in Company
6th May 20227:00 amRNSFull Year Trading Update
25th Feb 20227:00 amRNSAcquisition
23rd Feb 20225:50 pmRNSHolding(s) in Company
26th Jan 20227:00 amRNSTrading Update
24th Nov 20217:00 amRNSInterim Results
27th Oct 20217:00 amRNSAcquisition of Medichem Manufacturing
27th Sep 20217:00 amRNSH1 Trading Update and Notice of Results
20th Aug 202111:47 amRNSIssue of Shares under Share Incentive Plan & TVR
23rd Jul 202112:08 pmRNSImplementation of Long Term Incentive Plan
22nd Jul 20215:35 pmRNSNotification of Major Holdings
21st Jul 20217:00 amRNSNotification of Major Holdings
20th Jul 20215:59 pmRNSDirector Dealing
19th Jul 20217:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.